A phase I, open-label, dose-escalation study to assess the safety, tolerability and pharmacokinetics of AZD4877 administered weekly or every two weeks in patients with advanced solid malignancies

Trial Profile

A phase I, open-label, dose-escalation study to assess the safety, tolerability and pharmacokinetics of AZD4877 administered weekly or every two weeks in patients with advanced solid malignancies

Completed
Phase of Trial: Phase I

Latest Information Update: 12 May 2009

At a glance

  • Drugs AZD 4877 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 23 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Jun 2008 The expected completion date for this trial is now 1 Sep 2008, according to ClinicalTrials.gov.
    • 30 Jun 2008 Status changed from recruiting to in progress, reported by Clinicaltrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top